Cargando…
Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells
Paclitaxel (Taxol) resistance remains a major obstacle for the successful treatment of ovarian cancer. MicroRNAs (miRNAs) have oncogenic and tumor suppressor activity and are associated with poor prognosis phenotypes. miRNA screenings for this drug resistance are needed to estimate the prognosis of...
Autores principales: | Kim, Yong-Wan, Kim, Eun Young, Jeon, Doin, Liu, Juinn-Lin, Kim, Helena Suhyun, Choi, Jin Woo, Ahn, Woong Shick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938445/ https://www.ncbi.nlm.nih.gov/pubmed/24591819 http://dx.doi.org/10.2147/DDDT.S51969 |
Ejemplares similares
-
Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
por: Hou, Shunyu, et al.
Publicado: (2018) -
Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells
por: Choi, Eun Jeong, et al.
Publicado: (2008) -
Development of Multiplexed Bead-Based Immunoassays for the Detection of Early Stage Ovarian Cancer Using a Combination of Serum Biomarkers
por: Kim, Yong-Wan, et al.
Publicado: (2012) -
Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines
por: Wang, Xueqing, et al.
Publicado: (2013) -
Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.
por: Jekunen, A. P., et al.
Publicado: (1994)